The problem of representativeness of clinical trial participants: understanding the role of hidden costs
J Health Serv Res Policy
.
2016 Jul;21(3):145-6.
doi: 10.1177/1355819616630568.
Epub 2016 Feb 16.
Authors
Hala Borno
1
,
Adam Siegel
2
,
Charles Ryan
3
Affiliations
1
UCSF Medical Center, 505 Parnassus Ave, San Francisco, CA 94143, USA. hala.borno@ucsf.edu.
2
Hematologist/Oncologist, Aurora BayCare Medical Center.
3
Professor of Medical Oncology, University of California at San Francisco, CA.
PMID:
26888478
DOI:
10.1177/1355819616630568
No abstract available
Publication types
Editorial
MeSH terms
Clinical Trials as Topic / economics*
Clinical Trials as Topic / legislation & jurisprudence
Costs and Cost Analysis
Humans
Patient Selection*
Research Subjects / statistics & numerical data*
United States